Search
Roche Fast Covid-19 Test Shares Rise after FDA Approval $RHHBY
- Chronicle Trade Group
- Mar 14, 2020
- 1 min read
Roche Holding AG Swiss drug maker, the first high-speed coronavirus test was approved by the United States Food and Drug Administration.
The company states it has the capacity to perform millions of tests per month on its cobas 6800 and 8800 system application. Has the speed to process up to 4k of the Covid-19 tests per hour.
Shares of ROCHE rise after FDA approval, report earnings March 19, 2020, could be a earnings surprise, recent support levels established at $35 price closed March 13 at $40.30
